SEVERIN, THOMAS,LOWE, PHIL,JANOCHA, REINHOLD,KOEHNE-VOSS, STEPHAN
申请号：
CA3094749
公开号：
CA3094749A1
申请日:
2019.03.25
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using IgE antagonists, e.g., ligelizumab. Also disclosed herein are IgE antagonists, e.g., IgE antibodies, such as ligelizumab, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
